AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Aug 14, 2025
31676_dirs_2025-08-14_c78d2332-626c-41e6-b01f-d2fde3817b93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-08-12
Reporting Person: CAREY STEPHEN P. (SVP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-12 | Common Stock | M | 50000 | $46.49 | Acquired | 230863 | Direct |
| 2025-08-12 | Common Stock | S | 50000 | $86.07 | Disposed | 180863 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-12 | Stock Option (right to buy) | $46.49 | M | 50000 | Disposed | 2026-05-05 | Common Stock (50000) | Direct |
Footnotes
F1: 25% of the total options vested on each of May 6, 2017, May 6, 2018, May 6, 2019, and May 6, 2020.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3